Therapeutic Peptides Expanded intermediate
Oncology / GnRH Antagonist (oral)
Field
By Encyclopeptide Editorial | 1 min read
therapeutic-peptides-expanded peptide oligopeptide
Overview
Oncology / GnRH Antagonist (oral) is a peptide compound with applications in research and therapeutics. Field
Chemical Identity
| Property | Value |
|---|---|
| Name | Oncology / GnRH Antagonist (oral) |
| Sequence | --- |
19. Elagolix |
| Length | 21 amino acids |
| Category | Therapeutic Peptides Expanded |
Structure
Oncology / GnRH Antagonist (oral) belongs to the Therapeutic Peptides Expanded class of peptides. Its structure and properties make it suitable for various research and therapeutic applications.
Applications
Oncology / GnRH Antagonist (oral) has been studied for its potential applications in:
- Biomedical research
- Drug discovery
- Diagnostic applications
- Therapeutic development
References
- Source: therapeutic-peptides-expanded.md
- Database: Wikipept Peptide Database
Test Your Knowledge
Reinforce what you learned about Oncology / GnRH Antagonist (oral) with interactive quizzes on Wikipept.
Take a Quiz on Wikipept